Zhejiang Medicine Co (SHSE:600216) Tariff Resilience Score: 0/10 (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600216 Zhejiang Medicine Co Ltd SHSE:600216
78 GF Score
Price ¥12.17
GF Value ¥13.84
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Zhejiang Medicine Co Tariff Resilience Score?

Zhejiang Medicine Co has the Tariff Resilience Score of 0, which implies that the company might have .

Zhejiang Medicine Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Zhejiang Medicine Co might have .

Zhejiang Medicine Co  (SHSE:600216) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Zhejiang Medicine Co Tariff Resilience Score Related Terms

SHSE:600216
78GF Score
Zhejiang Medicine Co Ltd SHSE:600216
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhejiang Medicine Co (SHSE:600216) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Medicine Co stock appears to be undervalued. The current stock price of ¥12.17 is trading 12.1% below its estimated GF Value™ of ¥13.84. GuruFocus considers Zhejiang Medicine Co to be Modestly Undervalued.

Key valuation signals for SHSE:600216:

  • Tariff Resilience Score: 0
  • GF Value™: ¥13.84 vs. price of ¥12.17 (12.1% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600216 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Medicine Co Business Description

Address Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366
Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.
78GF Score

Get the complete analysis for SHSE:600216

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.17
Price
¥13.84
GF Value